We are live on ! Find out more
ARCT icon

Arcturus Therapeutics

113 hedge funds and large institutions have $379M invested in Arcturus Therapeutics in 2022 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 38 increasing their positions, 36 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

123% more call options, than puts

Call options by funds: $6.67M | Put options by funds: $2.99M

16% more capital invested

Capital invested by funds: $328M → $379M (+$51.2M)

2.06% more ownership

Funds ownership: 83.4%85.46% (+2.1%)

6% more repeat investments, than reductions

Existing positions increased: 38 | Existing positions reduced: 36

5% less first-time investments, than exits

New positions opened: 19 | Existing positions closed: 20

3% less funds holding

Funds holding: 116113 (-3)

Holders
113
Holders Change
-3
Holders Change %
-2.59%
% of All Funds
1.82%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
19
Increased
38
Reduced
36
Closed
20
Calls
$6.67M
Puts
$2.99M
Net Calls
+$3.68M
Net Calls Change
+$1.69M
Name Holding Trade Value Shares
Change
Change in
Stake
Bank of New York Mellon
26
Bank of New York Mellon
New York
$1.3M +$17.2K +986 +1%
N
27
Nuveen
North Carolina
$1.16M -$724K -41,541 -38%
HWAM
28
Hennion & Walsh Asset Management
New Jersey
$1.14M +$123K +7,072 +12%
Bank Julius Baer & Co
29
Bank Julius Baer & Co
Switzerland
$1.13M +$117K +6,707 +11%
Vontobel Holding
30
Vontobel Holding
Switzerland
$1.12M -$122K -6,994 -10%
Point72 Asset Management
31
Point72 Asset Management
Connecticut
$1.09M -$9.64M -552,624 -90%
HF
32
HRT Financial
New York
$1.02M +$1.05M +60,482 New
Swiss National Bank
33
Swiss National Bank
Switzerland
$979K +$31.4K +1,800 +3%
Susquehanna International Group
34
Susquehanna International Group
Pennsylvania
$970K -$1.15M -65,779 -54%
CSS
35
Cubist Systematic Strategies
Connecticut
$931K +$957K +54,865 New
PVI
36
Pura Vida Investments
New York
$848K +$872K +50,000 New
Wellington Management Group
37
Wellington Management Group
Massachusetts
$746K -$4.34K -249 -0.6%
Millennium Management
38
Millennium Management
New York
$702K +$400K +22,926 +124%
Deutsche Bank
39
Deutsche Bank
Germany
$676K +$511K +29,300 +277%
CS
40
Credit Suisse
Switzerland
$636K +$77.4K +4,437 +13%
Group One Trading
41
Group One Trading
Illinois
$613K +$135K +7,739 +27%
California State Teachers Retirement System (CalSTRS)
42
California State Teachers Retirement System (CalSTRS)
California
$509K +$7.27K +417 +1%
ECM
43
ExodusPoint Capital Management
New York
$506K -$309K -17,736 -37%
RhumbLine Advisers
44
RhumbLine Advisers
Massachusetts
$495K +$16K +915 +3%
Mackenzie Financial
45
Mackenzie Financial
Ontario, Canada
$485K +$499K +28,612 New
Invesco
46
Invesco
Georgia
$430K -$17.2K -988 -4%
BNP Paribas Financial Markets
47
BNP Paribas Financial Markets
France
$427K -$613K -35,149 -58%
MOS
48
MGO One Seven
Ohio
$420K -$94.6K -5,425 -18%
GAA
49
Green Alpha Advisors
Colorado
$398K +$1.38K +79 +0.3%
AllianceBernstein
50
AllianceBernstein
Tennessee
$387K

ARCT Hedge Fund Activity: Q4 2022 in Review

113 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Arcturus Therapeutics (ARCT) for Q4 2022, worth a combined $379M — up 16% from $328M a quarter earlier.

Sellers outnumbered buyers: 20 funds closed out of ARCT and 19 opened new positions — a net loss of 1 holder — while 36 trimmed existing stakes and 38 added.

The largest buyer was Federated Hermes, adding an estimated $11.7M. The largest seller was Point72 Asset Management, cutting an estimated $9.64M.

  • 113 institutional investors held Arcturus Therapeutics (ARCT) as of Q4 2022, down from 116 in Q3 2022.
  • Funds reported $379M of Arcturus Therapeutics stock for Q4 2022, up 16% quarter-over-quarter.
  • 19 funds opened new Arcturus Therapeutics positions in Q4 2022 and 20 closed out, a net change of -1 holder.
  • The largest Arcturus Therapeutics buyer in Q4 2022 was Federated Hermes, an estimated $11.7M added.
  • The largest Arcturus Therapeutics seller in Q4 2022 was Point72 Asset Management, an estimated $9.64M sold.

Based on aggregated 13F filings for Q4 2022.